A Nutritional Management Algorithm in Older Patients With Locally Advanced Esophageal Cancer

Inclusion Criteria

• •Patients must be ≥ age of 65; no maximum age limit.
• •Patients who will receive induction chemotherapy followed by combined chemoradiotherapy at MSKCC for localized stage I-III esophageal or gastroesophageal junction cancer.
• •Patients can receive chemoradiotherapy preoperatively prior to surgical resection or as definitive/primary chemoradiotherapy.
• •Patients can be KPS ≥60, as long as primary provider feels that patient is candidate for combined modality chemoradiotherapy
• •Be able to provide informed consent